Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT003 MDI Dose Ranging in COPD
NCT01349816Phase 2Completed
- Sponsor
- Pearl Therapeutics
- Start
- Jun 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BEVESPI AEROSPHERE in chronic obstructive pulmonary disease (COPD), sponsored by Pearl Therapeutics. Started Jun 2011; status: completed.
02
Drugs
BEVESPI AEROSPHERE
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01349816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01349816.